Cancer stem cell dynamics in tumor progression and metastasis: is the microenvironment to blame?
- PMID: 23089245
- DOI: 10.1016/j.canlet.2012.10.015
Cancer stem cell dynamics in tumor progression and metastasis: is the microenvironment to blame?
Abstract
Stem cells are defined by their self-renewal capacity and the ability to give rise to all differentiated progeny necessary for one specific organ. These two characteristics are also inherent in cancer stem cells (CSCs), which are thought to be the only subpopulation within a tumor endowed with tumorigenic potential. CSCs combine many features that render cancer one of the leading causes of death in the Western world: metastasis, tumor recurrence, and therapy refractoriness. Strikingly, CSCs are not a fixed entity, but differentiated tumor cells are able to revert to a stem-like state. Thus, CSCs are not only intrinsically programmed to fulfill their detrimental roles, but are orchestrated by stromal cells residing in their vicinity and forming the CSC niche. Yet, this relationship is not a one-way road: CSCs are able to manipulate stromal cells to their needs, not only in the primary tumor, but also in distant organs and thus prime the foreign soil for their arrival by inducing a premetastatic niche. The suggested plasticity between the differentiation states of cancer cells and the regulation by microenvironmental cues provides new starting-points for novel cancer therapies.
Keywords: Cancer stem cells; Metastasis; Microenvironment; Wnt.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Cancer stem cell niche: the place to be.Cancer Res. 2011 Feb 1;71(3):634-9. doi: 10.1158/0008-5472.CAN-10-3220. Epub 2011 Jan 25. Cancer Res. 2011. PMID: 21266356 Review.
-
Cancer stem cells (CSCs) in cancer progression and therapy.J Cell Physiol. 2019 Jun;234(6):8381-8395. doi: 10.1002/jcp.27740. Epub 2018 Nov 11. J Cell Physiol. 2019. PMID: 30417375 Review.
-
Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.Adv Cancer Res. 2016;131:159-91. doi: 10.1016/bs.acr.2016.04.003. Epub 2016 Jun 3. Adv Cancer Res. 2016. PMID: 27451127 Review.
-
Pancreatic cancer stem cells: A state or an entity?Semin Cancer Biol. 2018 Dec;53:223-231. doi: 10.1016/j.semcancer.2018.08.007. Epub 2018 Aug 18. Semin Cancer Biol. 2018. PMID: 30130664 Review.
-
Tumor microenvironment for cancer stem cells.Adv Drug Deliv Rev. 2016 Apr 1;99(Pt B):197-205. doi: 10.1016/j.addr.2015.08.005. Epub 2015 Sep 8. Adv Drug Deliv Rev. 2016. PMID: 26362921 Review.
Cited by
-
Cellular and Molecular Mechanisms of Chemoresistance for Gastric Cancer.Int J Gen Med. 2024 Aug 29;17:3779-3788. doi: 10.2147/IJGM.S473749. eCollection 2024. Int J Gen Med. 2024. PMID: 39224691 Free PMC article. Review.
-
Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment.Cancers (Basel). 2021 Oct 28;13(21):5414. doi: 10.3390/cancers13215414. Cancers (Basel). 2021. PMID: 34771577 Free PMC article. Review.
-
The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity.Front Oncol. 2023 May 17;13:1170264. doi: 10.3389/fonc.2023.1170264. eCollection 2023. Front Oncol. 2023. PMID: 37265795 Free PMC article. Review.
-
Emerging role of tumor cell plasticity in modifying therapeutic response.Signal Transduct Target Ther. 2020 Oct 7;5(1):228. doi: 10.1038/s41392-020-00313-5. Signal Transduct Target Ther. 2020. PMID: 33028808 Free PMC article. Review.
-
Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer.Oncogene. 2019 Mar;38(12):2092-2107. doi: 10.1038/s41388-018-0562-z. Epub 2018 Nov 15. Oncogene. 2019. PMID: 30442981 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials